H. Juliette T. Unwin

H. Juliette T. Unwin

Auto-generated profile, based on publicly available information

H. Juliette T. Unwin

MRC Centre for Global Infectious Disease Analysis and WHO Collaborating Centre for Infectious Disease Modelling, Jameel Institute, School of Public Health, Imperial College London, London, UK; School of Mathematics, University of Bristol, Bristol, UK

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2020 in Nature
Verified
Journal Article
Closed access
PDF file
SFSeth Flaxman
Seth Flaxman
SMSwapnil Mishra
Swapnil Mishra
AGAxel Gandy
Axel Gandy
HUH. Juliette T. Unwin
H. Juliette T. Unwin
TMThomas A. Mellan
Thomas A. Mellan
SBSamir Bhatt
Samir Bhatt

24 July 2020 in Science
Verified
Journal Article
Open access
PDF file
PWPatrick G. T. Walker
Patrick G. T. Walker
CWCharles Whittaker
Charles Whittaker
OWOliver J. Watson
Oliver J. Watson
MBMarc Baguelin
Marc Baguelin
PWPeter Winskill
Peter Winskill
AGAzra C. Ghani
Azra C. Ghani
Global prospects for COVID-19 control: Lower-income countries have recognized the potential impact of coronavirus disease 2019 (COVID-19) from observing ongoing epidemics. Many have intervened quickly and early with measures to slow viral transmission, which may partly explain the low rates observed so far in these countries. Walker et al. calibrated a global model with country-specific data (see the Perspective by Metcalf et al. ). Despite the potentially protective effects of younger demographics, the closer intergenerational contact, limitations on health care facilities, and frequency of comorbidities in lower-income countries require sustained nonpharmaceutical interventions (NPIs) to avoid overwhelming health care capacity. As a result of strict NPIs, the protective effects of immunity will be reduced, and it will be important to improve testing capacity. Ensuring equitable provision of oxygen and—when they are ready—pharmaceutical interventions should be a global priority. Science , this issue p. 413 ; see also p. 368

1 September 2020 in The Lancet Global Health
Verified
Journal Article
Open access
AHAlexandra B Hogan
Alexandra B Hogan
BJBritta L Jewell
Britta L Jewell
ESEllie Sherrard-Smith
Ellie Sherrard-Smith
JVJuan F Vesga
Juan F Vesga
OWOliver J Watson
Oliver J Watson
THTimothy B Hallett
Timothy B Hallett
COVID-19 has the potential to cause substantial disruptions to health services, due to cases overburdening the health system or response measures limiting usual programmatic activities. We aimed to quantify the extent to which disruptions to services for HIV, tuberculosis, and malaria in low-income and middle-income countries with high burdens of these diseases could lead to additional loss of life over the next 5 years. Assuming a basic reproduction number of 3·0, we constructed four scenarios for possible responses to the COVID-19 pandemic: no action, mitigation for 6 months, suppression for 2 months, or suppression for 1 year. We used established transmission models of HIV, tuberculosis, and malaria to estimate the additional impact on health that could be caused in selected settings, either due to COVID-19 interventions limiting activities, or due to the high demand on the health system due to the COVID-19 pandemic. In high-burden settings, deaths due to HIV, tuberculosis, and malaria over 5 years could increase by up to 10%, 20%, and 36%, respectively, compared with if there was no COVID-19 pandemic. The greatest impact on HIV was estimated to be from interruption to antiretroviral therapy, which could occur during a period of high health system demand. For tuberculosis, the greatest impact would be from reductions in timely diagnosis and treatment of new cases, which could result from any prolonged period of COVID-19 suppression interventions. The greatest impact on malaria burden could be as a result of interruption of planned net campaigns. These disruptions could lead to a loss of life-years over 5 years that is of the same order of magnitude as the direct impact from COVID-19 in places with a high burden of malaria and large HIV and tuberculosis epidemics. Maintaining the most critical prevention activities and health-care services for HIV, tuberculosis, and malaria could substantially reduce the overall impact of the COVID-19 pandemic. Bill & Melinda Gates Foundation, Wellcome Trust, UK Department for International Development, and Medical Research Council.

17 February 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
PNPierre Nouvellet
Pierre Nouvellet
SBSangeeta Bhatia
Sangeeta Bhatia
ACAnne Cori
Anne Cori
KAKylie E. C. Ainslie
Kylie E. C. Ainslie
MBMarc Baguelin
Marc Baguelin
CDChristl A Donnelly
Christl A Donnelly
In response to the COVID-19 pandemic, countries have sought to control SARS-CoV-2 transmission by restricting population movement through social distancing interventions, thus reducing the number of contacts. Mobility data represent an important proxy measure of social distancing, and here, we characterise the relationship between transmission and mobility for 52 countries around the world. Transmission significantly decreased with the initial reduction in mobility in 73% of the countries analysed, but we found evidence of decoupling of transmission and mobility following the relaxation of strict control measures for 80% of countries. For the majority of countries, mobility explained a substantial proportion of the variation in transmissibility (median adjusted R-squared: 48%, interquartile range - IQR - across countries [27–77%]). Where a change in the relationship occurred, predictive ability decreased after the relaxation; from a median adjusted R-squared of 74% (IQR across countries [49–91%]) pre-relaxation, to a median adjusted R-squared of 30% (IQR across countries [12–48%]) post-relaxation. In countries with a clear relationship between mobility and transmission both before and after strict control measures were relaxed, mobility was associated with lower transmission rates after control measures were relaxed indicating that the beneficial effects of ongoing social distancing behaviours were substantial.

26 March 2021 in Science
Verified
Journal Article
Open access
PDF file
Mélodie MonodMélodie Monod
Mélodie Monod
ABAlexandra Blenkinsop
Alexandra Blenkinsop
XXXiaoyue Xi
Xiaoyue Xi
DHDaniel Hebert
Daniel Hebert
SBSivan Bershan
Sivan Bershan
OROliver Ratmann
Oliver Ratmann
Age-specific contact: How can the resurgent epidemics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during 2020 be explained? Are they a result of students going back to school? To address this question, Monod et al. created a contact matrix for infection based on data collected in Europe and China and extended it to the United States. Early in the pandemic, before interventions were widely implemented, contacts concentrated among individuals of similar age were the highest among school-aged children, between children and their parents, and between middle-aged adults and the elderly. However, with the advent of nonpharmaceutical interventions, these contact patterns changed substantially. By mid-August 2020, although schools reopening facilitated transmission, the resurgence in the United States was largely driven by adults 20 to 49 years of age. Thus, working adults who need to support themselves and their families have fueled the resurging epidemics in the United States. Science , this issue p. eabe8372

19 February 2025 in Nature
Verified
Journal Article
Closed access
PDF file
MKMoritz U. G. Kraemer
Moritz U. G. Kraemer
JTJoseph L.-H. Tsui
Joseph L.-H. Tsui
SCSerina Y. Chang
Serina Y. Chang
SLSpyros Lytras
Spyros Lytras
MKMark P. Khurana
Mark P. Khurana
SBSamir Bhatt
Samir Bhatt